Detalhe da pesquisa
1.
Response to Induction Neoadjuvant Hormonal Therapy Using Upfront 21-Gene Breast Recurrence Score Assay-Results From the SAFIA Phase III Trial.
JCO Glob Oncol
; 7: 811-819, 2021 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34086481